Get the full Pyxis Oncology company profile
Access contacts, investors, buying signals & more
Pyxis Oncology has raised $110.0M to advance its portfolio of biologics aimed at hard-to-treat cancers.
The company is developing antibody-drug conjugates and immunotherapies designed to target tumor cells directly while overcoming the immune suppression that helps tumors evade treatment.
Polsky 10: Pyxis secures up to $282.6M | Thrixel launches with new $3M | Inomagen receives $2.9M grant - Polsky Center for Entrepreneurship and Innovation Polsky 10: Pyxis secures up to $282.6M | Thrixel launches with new $3M | Inomagen receives $2.
9M grant - Polsky Center for Entrepreneurship and Innovation The Polsky 10 is a bi-weekly newsletter featuring 10 things to know from the University of Chicago鈥檚 Polsky Center. To get the Polsky 10 sent directly to your inbox every other Friday,聽 sign up here >> 1 // Pyxis Oncology announces up to $282.6M in new funding as it gears up for key clinical milestones. UChicago Startup Investment Progr
Lyte
Founded in 2013, Lyte is a platform that enables event creators, venues and artists to enhance their ticketing, ensure shows are full and keep fans happy. We鈥檙e bringing joy to the ticketing experience with a demand-first solution that offers returnability, simplicity and confidence for fans and event creators alike.
$165.0M Series c
today
Axari
Axari is the AI workforce for cybersecurity teams. Every security professional gets an AI Twin that works alongside them in Slack and Microsoft Teams. Your Twin understands your security world, works across your tools and teams, and keeps work moving 24/7. From investigating issues and finding owners to coordinating teams, following up, and verifying completion, Axari carries the busy work around security professionals so they can focus on the work that actually needs them. You + your AI Twin = indefatigable.
$45.0M Seed
today
Largest funding rounds in Biotechnology on Signalbase right now.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 |  Shockwave Medical United States | Unknown | $13.1B | 2y ago |
| 2 |  NeuroEM Therapeutics United States | Unknown |
Companies that recently closed a Unknown round.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 |  UnVeil Surgical Belgium | Unknown | $112.0K | today |
| 2 |  ambi United States | Unknown | $26.0M | today |
monumental
We believe there's a unique rapport between dreamers and doers, and we delight in engaging the creative mind, the innovative brand, the inspired organization. We are the makers. The architects. The inventors. We view technology as a craft and apply that thinking to apps that span mobile, social, and entertainment platforms鈥攂oth emergent and established. We strongly believe in bringing systemic value to any partnership we forge. We do not make disposable things; we focus on creating enduring, solid, scalable things. We believe in empathy. And soul. And simplicity of form. And the elegance and efficiency that are part and parcel of good design. We're fiercely attuned to the fact that it's people who use our products. We hold utmost respect for optimizing the human experience. With the mind of a start-up and the heart of an explorer, we believe in being a bridge to the possible. A catalyst for the fresh and new.
$32.0M Series b
today
| $7.2B |
| 2y ago |
| 3 |  GRAIL United States | Unknown | $7.1B | 2y ago |
| 4 |  Illumina United States | Unknown | $7.1B | 2y ago |
| 5 |  RemeGen Biosciences United States | Grant | $5.6B | 9mo ago |
| 3 |
 MyTVS India |
| Unknown |
| $44.0M |
| today |
| 4 |  HTMS Composites United Kingdom | Unknown | $1.7M | today |
| 5 |  Munro Vehicles United Kingdom | Unknown | $2.6M | today |
Contacts, investors, buying intent signals & tech stack.
Trusted by 200+ sales teams
See who invested in Pyxis Oncology and reach their contacts directly.
Start free trial
BrainFocus
Recently received
AltuSafe
Recently received
Health Force
Recently received
